참고문헌
- Agarwal A, Chakraborty P, Chakraborty DD, et al (2012). Phytosomes: complexation, Utilisation and Commerical Status. J Biol Active Prod from Nature, 2, 65-77. https://doi.org/10.1080/22311866.2012.10719111
- Akan Z, Garip AI (2013). Antioxidants may protect cancer cells from apoptosis signals and enhance cell viability. Asian Pac J Cancer Prev, 14, 4611-4. https://doi.org/10.7314/APJCP.2013.14.8.4611
- Bhattacharya S, Ghosh AK, (2009). Phytosomes: the emerging technology for enhancement of bioavailability of botanicals and nutraceuticals. Int J Aesthetic & Antiaging Med, 2, 1.
- Chian S, Li YY, Wang XJ, Tang XW (2014). Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the nrf2 pathway. Asian Pac J Cancer Prev, 15, 2911. https://doi.org/10.7314/APJCP.2014.15.6.2911
- Crunkhorn S (2012). Deal watch: abbott boosts investment in NRF2 activators for reducing oxidative stress. Nature Rev Drug Discov, 11, 96-6. https://doi.org/10.1038/nrd3655
- Di Pierro F1, Menghi AB, Barreca A, Lucarelli M, Calandrelli A (2009). Greenselect Phytosome as an adjunct to a low-calorie diet for treatment of obesity: a clinical trial. Altern Med Rev, 14, 154-60.
- Freag MS, Elnaggar YS, Abdallah OY (2013). Lyophilized phytosomal nanocarriers as platforms for enhanced diosmin delivery: optimization and ex vivo permeation. Int J Nanomedicine, 8, 2385-97.
- Gao AM, Ke ZP, Shi F, Sun GC, Chen H (2013). Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway. Chem Biol Interact, 206, 100-8. https://doi.org/10.1016/j.cbi.2013.08.008
- George VC, Naveen Kumar DR, Suresh PK, Kumar S, Kumar RA (2013). Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells. Asian Pac J Cancer Prev, 14, 631-7. https://doi.org/10.7314/APJCP.2013.14.2.631
- Hart P, Minshall R, Bonini M, et al. (2014). Caveolin-1-dependent regulation of cellular metabolism in breast cancer: role of Nrf-2 and MnSOD (693.19). FASEB J, 693, 19.
- Hu XF, Yao J, Gao SG, et al (2013). Nrf2 overexpression predicts prognosis and 5-FU resistance in gastric cancer. Asian Pac J Cancer Prev, 14, 5231-5. https://doi.org/10.7314/APJCP.2013.14.9.5231
-
Hwang JT, Park OJ, Lee YK, et al (2011). Anti-tumor effect of luteolin is accompanied by AMP-activated protein kinase and nuclear factor-
$I^{\circ}B$ modulation in HepG2 hepatocarcinoma cells. Int J Mol Med, 28, 25-31. - Khunluck T, Kukongviriyapan V, Puapairoj A, et al (2014). Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients. Asian Pac J Cancer Prev, 15, 299-304. https://doi.org/10.7314/APJCP.2014.15.1.299
- Kweon MH, Adhami VM, Lee JS, Mukhtar H (2006). Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem, 281, 33761-72. https://doi.org/10.1074/jbc.M604748200
- Li Y, Paonessa JD, Zhang Y (2012). Mechanism of chemical activation of Nrf2. PloS One, 7, 35122. https://doi.org/10.1371/journal.pone.0035122
- Lopez-Lazaro M (2009). Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem, 9, 31-59. https://doi.org/10.2174/138955709787001712
- Manthena S, Srinivas P (2010). Phytosomes in herbal drug delivery. J Natural Pharmaceuticals, 1, 14. https://doi.org/10.4103/2229-5119.73581
- Mathur M (2013). Phyto-complex and their role in enhancing efficacy of herbal drugs. MPIJPRI, 5, 118-25.
- Mukherjee K, Maiti K, Venkatesh M, Mukherjee PK (2008). Phytosome of hesperetin, a value added formulation with phytomolecules. 60th Indian Pharmaceutical Congress; 2008 Dec 12-14; New Delhi, India. p. 287.
- Pandurangan AK, Dharmalingam P, Ananda Sadagopan SK, Ganapasam S (2012). Effect of luteolin on the levels of glycoproteins during azoxymethane-induced colon carcinogenesis in mice. Asian Pac J Cancer Prev, 13, 1569-73. https://doi.org/10.7314/APJCP.2012.13.4.1569
- Ren D, Villeneuve NF, Jiang T (2011). Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci USA, 108, 1433-8. https://doi.org/10.1073/pnas.1014275108
- Samadi N, Bekele RT, Goping IS, Schang LM, Brindley DN (2011). Lysophosphatidate induces chemo-resistance by releasing breast cancer cells from taxol-induced mitotic arrest. PloS one, 6, e20608. https://doi.org/10.1371/journal.pone.0020608
- Samadi N, Gaetano C, Goping IS, Brindley DN (2009). Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis. Oncogene, 28, 1028-39. https://doi.org/10.1038/onc.2008.442
- Shen H, Zhou S, Wang J (2013). The paradoxical role of Nrf2 in tumor biology. Crit Rev Eukaryot Gene Expr, 23, 37-47. https://doi.org/10.1615/CritRevEukarGeneExpr.2013006288
- Suryawanshi S (2011). Phytosome: an emerging trend in herbal drug treatment. J Med Gene Geno, 3, 109-14.
- Tabasinezhad M, Samadi N1, Ghanbari P, et al (2013). Sphingosin 1-phosphate contributes in tumor progression. J Cancer Res Ther, 9, 556-63. https://doi.org/10.4103/0973-1482.126446
- Tang JC1, Shi HS, Wan LQ, Wang YS, Wei YQ (2013). Enhanced antitumor effect of curcumin liposomes with local hyperthermia in the LL/2 model. Asian Pac J Cancer Prev, 14, 2307-10. https://doi.org/10.7314/APJCP.2013.14.4.2307
- Tang X, Wang H, Fan L (2011). Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs. Free Radic Biol Med, 50, 1599-609. https://doi.org/10.1016/j.freeradbiomed.2011.03.008
- Xu K1, Liu B, Ma Y (2009). Physicochemical properties and antioxidant activities of luteolin-phospholipid complex. Molecules, 14, 3486-93. https://doi.org/10.3390/molecules14093486
- Zhao Y, Yang G, Ren D (2011). Luteolin suppresses growth and migration of human lung cancer cells. Mol Biol Rep, 38, 1115-9. https://doi.org/10.1007/s11033-010-0208-x
- Zhu CY1, Lv YP, Yan DF, Gao FL (2013). Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells. Asian Pac J Cancer Prev, 14, 6757-60. https://doi.org/10.7314/APJCP.2013.14.11.6757
- Zucker SN, Fink EE, Bagati A (2014). Nrf2 amplifies oxidative stress via induction of Klf9. Mol cell, 53, 916-28. https://doi.org/10.1016/j.molcel.2014.01.033
피인용 문헌
- Arsenic Trioxide Promotes Paclitaxel Cytotoxicity in Resistant Breast Cancer Cells vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5191
- Silibilin-Induces Apoptosis in Breast Cancer Cells by Modulating p53, p21, Bak and Bcl-xl Pathways vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.2087
- Skin Redox Balance Maintenance: The Need for an Nrf2-Activator Delivery System vol.3, pp.1, 2016, https://doi.org/10.3390/cosmetics3010001
- Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells vol.43, pp.2, 2016, https://doi.org/10.1007/s11033-016-3942-x